Sarepta Therapeutics, Inc. (SRPT) operating margin

Operating margin · fiscal 2025
-29.9%

Sarepta Therapeutics, Inc. (SRPT) had an operating margin of -29.9% in fiscal 2025 (the year ended December 31, 2025). That is 41.4 percentage points lower than the 11.5% of fiscal 2024. Figures as of 17 Nov 2026, 22:07 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Operating margin, fiscal 2025
-29.9%
Change on fiscal 2024
−41.4 pts
Highest on record
11.5%fiscal 2024
Lowest on record
-17572.5%fiscal 2015
Fiscal years on record
122014–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Sarepta Therapeutics, Inc. operating margin, in more detail

Across the 12 fiscal years on record (2014–2025), the highest was 11.5% in fiscal 2024 and the lowest -17572.5% in fiscal 2015. The fiscal 2025 figure is higher than in 82% of the 11 earlier fiscal years on record, whose median is -114.1%.

Gross margin was 61.8% in fiscal 2025. Net margin was -32.5% in fiscal 2025.

History · 12 fiscal years

Operating margin by fiscal year

  • Operating margin
  • Gross margin
  • Net margin

Sarepta Therapeutics, Inc. operating margin, year by year

Sarepta Therapeutics, Inc. (SRPT) operating margin by fiscal year
Fiscal yearOperating marginChangeYear endedGross marginNet margin
2025-29.9% 41.4 pts down61.8%-32.5%
202411.5% 33.0 pts up83.2%12.4%
2023-21.5% 35.9 pts up87.9%-43.1%
2022-57.5% 17.6 pts up85.0%-75.4%
2021-75.1% 48.7 pts up—-68.4%
2020-123.8% 61.5 pts up—-121.6%
2019-185.3% 71.1 pts down—-187.8%
2018-114.1% 3.1 pts down—-120.2%
2017-111.0% 4809.3 pts up—-32.8%
2016-4920.3% 12652.2 pts up—-4930.2%
2015-17572.5% 16201.3 pts down—-17560.3%
2014-1371.2%——-1391.7%

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

How to read it

It shows how much of each unit of sales survives the cost of running the business — rising margins point to pricing power or scale, falling ones to pressure.

More on SRPT

Sarepta Therapeutics, Inc., figure by figure

Sarepta Therapeutics, Inc. (SRPT) overview: price, valuation and scorecard

Sarepta Therapeutics, Inc. operating margin: questions and answers

What is Sarepta Therapeutics, Inc.'s operating margin?

Sarepta Therapeutics, Inc. (SRPT) had an operating margin of -29.9% in fiscal 2025 (the year ended December 31, 2025). That is 41.4 percentage points lower than the 11.5% of fiscal 2024.

Is Sarepta Therapeutics, Inc.'s operating margin high or low compared with its own history?

The fiscal 2025 figure is higher than in 82% of the 11 earlier fiscal years on record, whose median is -114.1%.

What are the highest and lowest operating margin figures on record for Sarepta Therapeutics, Inc.?

Across the 12 fiscal years on record (2014–2025), the highest was 11.5% in fiscal 2024 and the lowest -17572.5% in fiscal 2015.

What are Sarepta Therapeutics, Inc.'s gross and net margins?

Gross margin was 61.8% in fiscal 2025. Net margin was -32.5% in fiscal 2025.

How is Sarepta Therapeutics, Inc.'s operating margin calculated?

Operating margin is operating income divided by revenue; gross margin does the same with gross profit, and net margin with net income.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sarepta Therapeutics, Inc. (SRPT) operating margin”, data as of 17 November 2026. https://funkfolio.com/stock/SRPT/operating-margin

Underlying data: the company's filings with the SEC and Yahoo Finance.